Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
0.0924
-0.0268 (-22.48%)
At close: Nov 20, 2024, 4:00 PM
0.0890
-0.0034 (-3.68%)
Pre-market: Nov 21, 2024, 7:41 AM EST
Eyenovia Employees
Eyenovia had 57 employees as of December 31, 2023. The number of employees increased by 16 or 39.02% compared to the previous year.
Employees
57
Change (1Y)
16
Growth (1Y)
39.02%
Revenue / Employee
$558
Profits / Employee
-$663,698
Market Cap
7.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Star Equity Holdings | 171 |
T2 Biosystems | 113 |
PAVmed | 107 |
BiomX | 71 |
NKGen Biotech | 63 |
Senti Biosciences | 48 |
Imunon | 33 |
Dominari Holdings | 28 |
EYEN News
- 5 days ago - Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - Benzinga
- 6 days ago - Eyenovia to discontinue late-stage study for eye drug - Reuters
- 6 days ago - Eyenovia Provides Update on Phase 3 CHAPERONE Study - GlobeNewsWire
- 8 days ago - Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th - GlobeNewsWire
- 5 weeks ago - Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo - GlobeNewsWire
- 7 weeks ago - Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device - GlobeNewsWire
- 7 weeks ago - Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering - GlobeNewsWire